carnitine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The relationship between reserve of L-carnitine and severity in patients with Amyotrophic lateral sclerosis (ALS) is not studied sufficiently." | 8.02 | The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis. ( Abaj, F; Asl Motallebnejad, Z; Bitarafan, S; Fathi, D; Nafissi, S; Sarraf, P; Teimouri, R; Vahedi, K, 2021) |
| "The relationship between reserve of L-carnitine and severity in patients with Amyotrophic lateral sclerosis (ALS) is not studied sufficiently." | 4.02 | The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis. ( Abaj, F; Asl Motallebnejad, Z; Bitarafan, S; Fathi, D; Nafissi, S; Sarraf, P; Teimouri, R; Vahedi, K, 2021) |
| "The carnitine concentration was significantly higher in patients than in their spouses, while there were no significant differences in the concentrations of other metabolites." | 1.56 | Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis. ( Chen, L; Chen, Y; Fan, D; Zhao, M; Zheng, L, 2020) |
| "L-carnitine treatment increased the mitochondrial enzyme activities in cortical regions towards control value and was effective in enhancing QO2 and decreasing TBARS levels in the spinal cord of mndT." | 1.31 | Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. ( Bertamini, M; Bigini, P; Curti, D; Guarneri, P; Guarneri, R; Marzani, B; Mennini, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Goutman, SA | 1 |
| Boss, J | 1 |
| Guo, K | 1 |
| Alakwaa, FM | 1 |
| Patterson, A | 1 |
| Kim, S | 1 |
| Savelieff, MG | 1 |
| Hur, J | 1 |
| Feldman, EL | 1 |
| Chen, L | 1 |
| Chen, Y | 1 |
| Zhao, M | 1 |
| Zheng, L | 1 |
| Fan, D | 1 |
| Sarraf, P | 1 |
| Bitarafan, S | 1 |
| Nafissi, S | 1 |
| Fathi, D | 1 |
| Abaj, F | 1 |
| Asl Motallebnejad, Z | 1 |
| Teimouri, R | 1 |
| Vahedi, K | 1 |
| Bertamini, M | 1 |
| Marzani, B | 1 |
| Guarneri, R | 1 |
| Guarneri, P | 1 |
| Bigini, P | 1 |
| Mennini, T | 1 |
| Curti, D | 1 |
| Kira, Y | 1 |
| Nishikawa, M | 1 |
| Ochi, A | 1 |
| Sato, E | 1 |
| Inoue, M | 1 |
| Sanjak, M | 1 |
| Paulson, D | 1 |
| Sufit, R | 1 |
| Reddan, W | 1 |
| Beaulieu, D | 1 |
| Erickson, L | 1 |
| Shug, A | 1 |
| Brooks, BR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Moderate Aerobic Exercise as Determined by Cardiopulmonary Exercise Testing in ALS[NCT03326622] | 48 participants (Actual) | Interventional | 2013-07-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for carnitine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
ALSUntangled 53: Carnitine supplements.
Topics: Amyotrophic Lateral Sclerosis; Carnitine; Dietary Supplements; Humans | 2020 |
Untargeted metabolomics yields insight into ALS disease mechanisms.
Topics: Aged; Amyotrophic Lateral Sclerosis; Benzoates; Carnitine; Case-Control Studies; Ceramides; Creatine | 2020 |
Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Betaine; Carnitine; Choline; Female; Gastrointestinal Microbiome; Hum | 2020 |
The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Body Mass Index; Carnitine; Cross-Sectional | 2021 |
Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Carnitine; Central Nervous System; Cerebral Cor | 2002 |
L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
Topics: Adenine; Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Carnitine; Disease Progression; Female; | 2006 |
Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis.
Topics: 3-Hydroxybutyric Acid; Amyotrophic Lateral Sclerosis; Carnitine; Exercise Test; Fatty Acids, Noneste | 1987 |